Europe: Putting Off Off-label Decisions | Pharmaceutical Executive
www.pharmexec.com › europe-putting-l...
Mar 16, 2015 - The EU's proposed new study on off-label prescribing is just another way of kicking the issue into the ... for collusion in seeking to protect profits from Lucentis by opposing off-label prescribing of Avastin.
No comments:
Post a Comment